October 9, 2024

You are invited to join our President and CEO, Paul J. Diaz, and other members of the Myriad Leadership team, for the upcoming Myriad Genetics Investor Event. We will share our long-term growth strategy operational initiatives, and scientific and clinical advancements reflected in our product pipeline, as well as long-term financial goals.

Register to attend the event online

Events & Presentations

  • Investor Day 2024

    10/09/2024 | 6:00am PDT / 9:00am EDT

    Watch the webcast

  • Morgan Stanley 22nd Annual Global Healthcare Conference

    09/05/2024 | 4:00am PDT / 7:00am EDT

    Watch the webcast

  • Wells Fargo Healthcare Conference 2024

    09/04/2024 | 10:30am PDT / 1:30pm EDT

    Watch the webcast
View all events

Financial Reports and Filings

Date Filing Title Downloads
09/16/2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing RTF XLS PDF HTML XBRL
09/12/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/12/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/11/2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing RTF XLS PDF HTML XBRL
09/11/2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing RTF XLS PDF HTML XBRL
09/09/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/09/2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing RTF XLS PDF HTML XBRL
09/04/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/04/2024 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
09/04/2024 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics to Host Investor Event on October 9, 2024 Thumbnail

Myriad Genetics to Host Investor Event on October 9, 2024

Sep 05, 2024 | Corporate

Read more
Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences Thumbnail

Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Aug 21, 2024 | Corporate

Read more
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12% Thumbnail

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Aug 06, 2024 | Financial | Corporate

Read more
View all news releases

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

Read our ESG report
“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

Read our ESG report
“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics